Company Name | Bristol-Myers Squibb Company |
---|---|
Website | https://www.bms.com |
Snippet | 2022 Fourth Quarter and Full-Year Results. Bristol Myers Squibb reports fourth quarter revenues of $11.4 billion; GAAP EPS of $0.95 and non-GAAP EPS of $1.82 which includes a net impact of ($0.01) per share due to Acquired IPRD charges and licensing income. |
Type | Public |
Founded | 1887 |
Revenue | US$26.15 billion (2019)[1] |
Website | BMS.com |
Founders | William McLaren Bristol John Ripley Myers E. R. Squibb |
Industry | Pharmaceuticals |
Traded as | NYSE: BMYS&P 100 componentS&P 500 component |
Key people | Giovanni Caforio, M.D.(Chairman & CEO)Charles Bancroft(CFO) |
Net income | US$3.46 billion (2019)[1] |
Headquarters | 430 East 29th StreetNew York City, New York, United States |
Total assets | US$129.44 billion (2019)[1] |
Total equity | US$59.70 billion (2019)[1] |
Operating income | US$18.06 billion (2019)[1] |
Number of employees | 30,000 (2019)[1] |
Bristol-Myers Squibb Company is part of the United States company list
Bristol-Myers Squibb Company is part of the Pharmaceuticals company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us